Annual report [Section 13 and 15(d), not S-K Item 405]

COMMON STOCK

v3.25.1
COMMON STOCK
12 Months Ended
Dec. 31, 2024
COMMON STOCK  
COMMON STOCK

NOTE 9. COMMON STOCK

 

The Company’s common stock transactions for the year ended December 31, 2024 consisted of the following:

 

The Company issued 105 shares of common stock for RSUs vested during 2024.

 

The Company issued 5,214 shares of common stock upon conversion of a portion of the Convertible Notes issued in the 2023 Debt Offering.

 

The Company issued 358 shares of common stock in connection with the rounding provisions of the 1-for-110 reverse stock split conducted on October 2, 2024.

 

On October 9, 2024, the Company received $7,336,295 of net proceeds from the sale of 202,470 PIPE units at an offering price of $40.50 per PIPE unit, each unit consisting of (i) one share of common stock, par value 0.00001 per share, of the Company, or one pre-funded warrant in lieu thereof, (ii) two Series A Warrants, each to purchase one share of common stock at an exercise price of $38 per share, and (iii) one Series B Warrant to purchase such number of shares of common stock as will be determined on the Reset Date, as defined. Upon closing of the Private Placement, the Company issued 41,469 common shares and 161,000 pre-funded warrants.

 

The Company issued 872,874 shares of common stock upon exercise of warrants during 2024.

 

The Company’s common stock transactions for the year ended December 31, 2023 consisted of the following:

 

The Company issued 205 shares of common stock to a consultant for investor relations services.

 

The Company issued 214 shares of its common stock for RSUs vested during 2023.

 

The Company issued 137 shares of its common stock upon conversion of a portion of the Convertible Notes issued in the 2023 Debt Offering.

 

The Company exchanged 3,000,000 shares of Series B Convertible Preferred Stock with related parties for 910 shares of common stock (see Notes 10)